Samyang Biopharm Corporation (KRX:0120G0)
South Korea · Delayed Price · Currency is KRW 100,000
-2,900 (-2.82%)
Last updated: Feb 4, 2026, 12:25 PM KST
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 745.07 billion as of February 5, 2026.
Market Cap
745.07B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
100,000.00
Market Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 745.07B, an increase of 231.79%. That is a compound annual growth rate of 43,599.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 745.07B | 90.86% |
| Dec 30, 2025 | 390.38B | 73.84% |
| Nov 24, 2025 | 224.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HK inno.N | 1.54T |
| G2GBIO | 1.37T |
| Myung In Pharmaceutical LTD. | 911.04B |
| ImmuneOncia Therapeutics | 781.70B |
| HEM Pharma | 670.46B |
| CellBion | 321.43B |
| DAE HWA Pharmaceutical | 282.72B |
| NOVAREX | 258.10B |